The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

The COVID-19 pandemic is over, but the vaccine controversy is not. It's time to take a step back and review the new HHS ...

America's pediatricians and the Centers for Disease Control and Prevention were once in lockstep on how vaccines impact child ...

The risk of a child dying from a COVID-19 vaccine is far lower than dying in a car accident. COVID-19 vaccines are effective in preventing hospitalizations, urgent care visits and long COVID in ...

Partisan attacks on public health initiatives are undermining efforts to control COVID-19. Claims linking COVID-19 vaccines to pediatric deaths are disputed, citing data on hospitalizations and long ...

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...

Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated ...

Robert Kramer was the CEO of Emergent BioSolutions, a government contractor.